Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:II-187-II-193

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friehs, I.
Right arrow Articles by del Nido, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friehs, I.
Right arrow Articles by del Nido, P. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
*Heart Surgery
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Animal models of human disease
Right arrow Hypertrophy
Right arrow Echocardiography

(Circulation. 1999;100:II-187.)
© 1999 American Heart Association, Inc.


Surgery for Congenital Heart Disease

Impaired Glucose Transporter Activity in Pressure-Overload Hypertrophy Is an Early Indicator of Progression to Failure

Ingeborg Friehs, MD; Adrian M. Moran, MD; Christof Stamm, MD; Steven D. Colan, MD; Koh Takeuchi, MD; Hung Cao-Danh, PhD; Christine M. Rader, BA; Francis X. McGowan, MD; Pedro J. del Nido, MD

From the Departments of Cardiac Surgery (I.F., C.S., K.T., H.C.-D., C.M.R., P.J.d.N.), Pediatric Cardiology (A.M.M., S.D.C.), and Anesthesiology (F.X.M.), The Children’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Pedro J. del Nido, MD, Department of Cardiac Surgery, Children‘s Hospital, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115. E-mail delnido{at}A1.tch.harvard.edu

Background—Severe hypertrophy and heart failure are important risk factors in cardiac surgery. Early adaptive changes in hypertrophy include increased ventricular mass-to-cavity volume ratio (M/V ratio) and increased dependence on glucose for energy metabolism. However, glucose uptake is decreased in the late stages of hypertrophy when ventricular dilatation and failure are present. We hypothesized that impaired glucose uptake would be evident early in the progression of hypertrophy and associated with the onset of ventricular dilatation.

Methods and Results—Ten-day-old rabbits underwent banding of the descending aorta. Development of hypertrophy was followed by transthoracic echocardiography to measure left ventricular M/V ratio. Glucose uptake rate, as determined by 31P-nuclear magnetic resonance spectroscopy measuring 2-deoxyglucose conversion to 2-deoxyglucose-6-phosphate, was measured in isolated perfused hearts obtained from banded rabbits when M/V ratio had increased by 15% from baseline (compensated hypertrophy) and by 30% from baseline (early-decompensated hypertrophy). In age-matched control animals, the rate of glucose uptake was 0.61±0.08 µmol · g of wet weight-1 · 30 min-1 (mean±SEM). With a 15% M/V ratio increase, glucose uptake rate remained at control levels (0.6±0.05 µmol · g of wet weight-1 · 30 min-1), compared with hearts with 30% increased M/V ratios, where glucose uptake was significantly lower (0.42±0.05 µmol · g of wet weight-1 · 30 min-1; P<=0.05). Glucose transporter protein expression was the same in all groups.

Conclusions—Glucose uptake rate is maintained during compensated hypertrophy. However, coinciding with severe hypertrophy, preceding ventricular dilatation, and glucose transporter protein downregulation, glucose uptake is significantly decreased. Because of the increased dependence of the hypertrophied hearts on glucose use, we speculate that this impairment may be a contributing factor in the progression to failure.


Key Words: hypertrophy • echocardiography • glucose • metabolism